Overexpression of MYC, BCL2, and BCL6 genes plays a critical role in the pathogenesis of DLBCL, with reported frequencies ranging from 8% to 40% of DLBCL cases [28,29]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.